- Home
- VNET vs FOLD Comparison
VNET vs FOLD Comparison
Compare VNET & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNET
- FOLD
- Stock Information
- Founded
- VNET 1999
- FOLD 2002
- Country
- VNET China
- FOLD United States
- Employees
- VNET N/A
- FOLD N/A
- Industry
- VNET Computer Software: Programming Data Processing
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- VNET Technology
- FOLD Health Care
- Exchange
- VNET Nasdaq
- FOLD Nasdaq
- Market Cap
- VNET 2.4B
- FOLD 2.9B
- IPO Year
- VNET 2011
- FOLD 2007
- Fundamental
- Price
- VNET $8.25
- FOLD $8.43
- Analyst Decision
- VNET Strong Buy
- FOLD Strong Buy
- Analyst Count
- VNET 3
- FOLD 9
- Target Price
- VNET $10.73
- FOLD $17.00
- AVG Volume (30 Days)
- VNET 11.9M
- FOLD 2.5M
- Earning Date
- VNET 03-12-2025
- FOLD 05-08-2025
- Dividend Yield
- VNET N/A
- FOLD N/A
- EPS Growth
- VNET N/A
- FOLD N/A
- EPS
- VNET 0.02
- FOLD N/A
- Revenue
- VNET $1,131,518,816.00
- FOLD $528,294,999.00
- Revenue This Year
- VNET $12.08
- FOLD $21.91
- Revenue Next Year
- VNET $15.15
- FOLD $22.22
- P/E Ratio
- VNET $87.59
- FOLD N/A
- Revenue Growth
- VNET 11.41
- FOLD 32.29
- 52 Week Low
- VNET $1.42
- FOLD $8.36
- 52 Week High
- VNET $16.13
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- VNET 38.68
- FOLD 35.37
- Support Level
- VNET $8.23
- FOLD $8.40
- Resistance Level
- VNET $9.07
- FOLD $9.26
- Average True Range (ATR)
- VNET 0.74
- FOLD 0.25
- MACD
- VNET -0.37
- FOLD -0.04
- Stochastic Oscillator
- VNET 9.09
- FOLD 7.78
About VNET VNET Group Inc.
VNET started as AsiaCloud in 1999 and moved to the data center business with its first self-developed data center opening in 2010. The firm listed (as 21Vianet) on the Nasdaq in April 2011, subsequently changing its name to VNET Group in 2021. It originally focused on providing data center services such as colocation and cloud services to retail clients in China, but added hyperscale customers in 2019 and now counts large Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud as customers. At the end of June 2024, it had 48,516 self-built retail cabinets with the majority in Beijing, Shanghai, and the Greater Bay area. It also had 358 MW of wholesale capacity in service with a further 297 MW under construction and a further 489 MW held for future development.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.